Literature DB >> 10075341

Comparison of growth status of patients with cystic fibrosis between the United States and Canada.

H C Lai1, M Corey, S FitzSimmons, M R Kosorok, P M Farrell.   

Abstract

BACKGROUND: Differences in growth status of patients with cystic fibrosis (CF) between the United States and Canada were reported in the 1980s based on analysis of data from 2 regional CF centers.
OBJECTIVE: We evaluated the current growth status of the entire CF population in the United States and Canada in view of recent advances in the treatment of CF.
DESIGN: Growth data from the 1992-1994 CF Patient Registries were analyzed.
RESULTS: Mean height and weight were at approximately the 30th percentile for children with CF in the United States. Mean height and weight were 4-5 percentiles higher in children with CF in Canada than in those in the United States (P < 0.01), but percentages of ideal weight (104%) were similar in both populations. In adults with CF, mean height was similar at the 37th percentile; however, weight (26th compared with the 21st percentiles) and percentage of ideal weight (93% compared with 90%) were significantly higher in Canada than in the United States. Differences related to sex and age were similar in both countries for all indexes, which showed a high prevalence of underweight in infants and in older patients, but little sex discrepancy.
CONCLUSION: We observed substantially smaller differences in the growth indexes of CF patients between the United States and Canada compared with results from the 1980s. These findings reflect significant improvements in the nutritional status of US patients in recent years. However, caution is required in the direct comparison of mean percentiles from reports using different growth standards because there are systematic differences in growth standards, which affect, in particular, the comparison of growth in males and females.

Entities:  

Mesh:

Year:  1999        PMID: 10075341     DOI: 10.1093/ajcn/69.3.531

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts.

Authors:  Jenna Sykes; Sanja Stanojevic; Christopher H Goss; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Josh Ostrenga; Aliza Fink; Alexander Elbert; Anne L Stephenson
Journal:  J Clin Epidemiol       Date:  2015-10-03       Impact factor: 6.437

2.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

3.  Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function.

Authors:  Rebecca Darrah; Rebecca Nelson; Elizabeth G Damato; Michael Decker; Anne Matthews; Craig A Hodges
Journal:  Biol Res Nurs       Date:  2016-04-13       Impact factor: 2.522

4.  Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.

Authors:  Moon Jeong Lee; Jessica A Alvarez; Ellen M Smith; David W Killilea; James F Chmiel; Patricia M Joseph; Ruth E Grossmann; Amit Gaggar; Thomas R Ziegler; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2015-06-15       Impact factor: 3.080

Review 5.  The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review.

Authors:  Isabelle R McKay; Chee Y Ooi
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

6.  Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Authors:  Aimee C Walsh; Gilles Rault; Zhanhai Li; Virginie Scotet; Ingrid Duguépéroux; Claude Férec; Michel Roussey; Anita Laxova; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2009-11-18       Impact factor: 5.482

7.  Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.

Authors:  G Steinkamp; B Wiedemann
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

8.  Genetic modifiers of nutritional status in cystic fibrosis.

Authors:  Gia M Bradley; Scott M Blackman; Christopher P Watson; Vishal K Doshi; Garry R Cutting
Journal:  Am J Clin Nutr       Date:  2012-11-07       Impact factor: 7.045

9.  A systematic review of studies comparing health outcomes in Canada and the United States.

Authors:  Gordon H Guyatt; Pj Devereaux; Joel Lexchin; Samuel B Stone; Armine Yalnizyan; David Himmelstein; Steffie Woolhandler; Qi Zhou; Laurie J Goldsmith; Deborah J Cook; Ted Haines; Christina Lacchetti; John N Lavis; Terrence Sullivan; Ed Mills; Shelley Kraus; Neera Bhatnagar
Journal:  Open Med       Date:  2007-04-14

Review 10.  Update of faecal markers of inflammation in children with cystic fibrosis.

Authors:  Jung M Lee; Steven T Leach; Tamarah Katz; Andrew S Day; Adam Jaffe; Chee Y Ooi
Journal:  Mediators Inflamm       Date:  2012-08-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.